Yalin Yin
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Yushida: an IoT-based smart injection system for long-term management of chronic diseases.
Journal: Frontiers in digital health
Published: June 05, 2026
Exploratory Pharmacokinetic Study of Pegylated Interferon Alfa-2b Aerosolized Inhalation Administration.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: August 20, 2025
Optimization of dosing regimens for the long-acting growth hormone pegpesen: A population PK/PD modeling approach.
Journal: Journal of endocrinological investigation
Published: August 13, 2025
Hepatitis B surface antigen clearance rate with pegylated interferon-α therapy in different chronic hepatitis B virus infection populations: A systematic review and meta-analysis.
Journal: Chinese medical journal
Published: July 14, 2025
Population Pharmacokinetic Model of Pegbing in Healthy Subjects and Chronic Hepatitis B Patients.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 11, 2025
Drug Repositioning of Pegbing® for Essential Thrombocythemia: Insights from PK/PD Modeling and Extrapolation.
Journal: Clinical pharmacology and therapeutics
Published: May 01, 2025
Hepatitis surface B antigen clearance induced by long-term tenofovir disoproxil fumarate monotherapy in chronic hepatitis B treatment: a meta-analysis and longitudinal modeling analysis.
Journal: Virology journal
Published: April 07, 2025
A Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 11, 2024
Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis.
Journal: Hepatology international
Published: October 07, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026